C12Y 204/99004
Beta-galactoside alpha-2,3-sialyltransferase
Official title: Beta-galactoside alpha-2,3-sialyltransferase (2.4.99.4)
C12Y204/99004 (Beta-galactoside alpha-2,3-sialyltransferase) appears on 17 US grants and 46 published applications in this corpus.
Search patents in C12Y- Granted patents
- 17
- Published applications
- 46
- Assignees
- 27
- Inventors
- 92
- Latest grant
- 28 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2008 | 0 | 1 |
| 2009 | 0 | 0 |
| 2010 | 0 | 1 |
| 2011 | 1 | 0 |
| 2012 | 1 | 1 |
| 2013 | 0 | 1 |
| 2014 | 0 | 1 |
| 2015 | 0 | 2 |
| 2016 | 0 | 1 |
| 2017 | 1 | 1 |
| 2018 | 1 | 2 |
| 2019 | 2 | 2 |
| 2020 | 3 | 4 |
| 2021 | 1 | 4 |
| 2022 | 2 | 4 |
| 2023 | 1 | 6 |
| 2024 | 1 | 7 |
| 2025 | 2 | 4 |
| 2026 | 1 | 4 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Sialyltransferases and their use in producing sialylated oligosaccharides28 Jul 2026US 12,692,524 B2Chr. Hansen A/S
- Oligosaccharide production in yeast cells expressing an ABC transporter protein15 Jul 2025US 12,359,234 B2Amyris, Inc.
- Sialyltransferases for in vivo synthesis of 3′SL7 Jan 2025US 12,188,056 B2Dsm IP Assets B.V.
- Production of a mixture of neutral non-fucosylated oligosaccharides by a cell3 Sep 2024US 12,077,788 B2Inbiose N.V.
- Sialyltransferase variants having neosialidase activity29 Aug 2023US 11,739,305 B2The Regents of the University of California
- Two-strain system for producing oligosaccharides9 Jul 2026US 2026/0193687 A1Dsm IP Assets B.V.
- Oligosaccharide production in yeast12 Mar 2026US 2026/0071245 A1Amyris, Inc.
- Production of a mixture of neutral fucosylated oligosaccharides by a cell26 Feb 2026US 2026/0055436 A1Inbiose N.V.
- New sialyltransferases for in vivo synthesis of 3'sl and 6'sl29 Jan 2026US 2026/0028634 A1
- Production of an oligosaccharide mixture by a cell27 Nov 2025US 2025/0361477 A1Inbiose N.V.
Most cited
By later US patents
- Automated bender and systems and methods for providing data to operate an automated bender7US 9,849,494 B2Textron Innovations Inc. · 2017
- Method for synthesis of sialylated products using reversible sialylation6US 8,278,072 B1Health Research, Inc. · 2012
- Methods for modifying human antibodies by glycan engineering5US 11,377,485 B2Academia Sinica · 2022
- O-glycan sialylated recombinant glycoproteins and cell lines for producing the same3US 10,081,798 B2Cevec Pharmaceuticals GmbH · 2018
- Optimized nucleic acid sequences coding for the alpha-chain of human chorionic gonadotropin2US 10,464,984 B2Ferring B. V. · 2019